Anthony Squeglia Net Worth & Insider Trades

Anthony Squeglia - Chief Financial Officer, Boston Therapeutics, Inc

As of March 11, 2015

What is Anthony Squeglia's Net Worth?

The current estimated net worth of Boston Therapeutics, Inc's Chief Financial Officer, Anthony Squeglia, is estimated to be about $1.28K . Anthony Squeglia owns about 128,350 units of Boston Therapeutics, Inc common stock. In the last year at Boston Therapeutics, Inc, Anthony Squeglia has sold an estimated value of $0 worth.

What is Anthony Squeglia's Past Insider Trading?

Anthony Squeglia's largest purchase order was 10,000 units , worth over $2.2K on March 11, 2015. In total, Anthony Squeglia has made about 2 transactions over a year of their time at Boston Therapeutics, Inc. Anthony Squeglia usually trades in March and April, with the busiest year in 2015 and 2014.

Anthony Squeglia

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Anthony Squeglia's' Mailing Address?

  • Mailing address is Pro-Pharmaceuticals, Inc. 7 Wells Avenue, Suite 34 Newton MA 02459 MA

What are Boston Therapeutics, Inc's Past Insider Trades?

Boston Therapeutics, Inc's most recent insider trade came on February 13, 2018 by Carl W Rausch who bought 0 unit worth $0 . In the last 6 years, insiders at Boston Therapeutics, Inc have sold an estimated value of $82.69K and bought an estimated value of $639.52K worth of shares. Insider trading is most common in January, with the busiest year in 2015. The most active traders at the company are David Platt, CEO and Chairman,  Anthony Squeglia, Chief Financial Officer,  and Dale H Conaway, Director .

Boston Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1